These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35146047)

  • 1. Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome.
    Milic J; Barbieri S; Gozzi L; Brigo A; Beghé B; Verduri A; Bacca E; Iadisernia V; Cuomo G; Dolci G; Yaacoub D; Aprile E; Belli M; Venuta M; Meschiari M; Sebastiani G; Clini E; Mussini C; Lonardo A; Guaraldi G; Raggi P
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac003. PubMed ID: 35146047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
    Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome?
    Milivojević V; Bogdanović J; Babić I; Todorović N; Ranković I
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629728
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis.
    Hayat U; Ashfaq MZ; Johnson L; Ford R; Wuthnow C; Kadado K; El Jurdi K; Okut H; Kilgore WR; Assi M; Siddiqui AA
    Kans J Med; 2022; 15():241-246. PubMed ID: 35899064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study.
    Adali G; Bilgic NM; Kalaman AE; Ozturk O; Ozdil K
    Hepatol Forum; 2023; 4(3):129-134. PubMed ID: 37822311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
    Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
    Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China.
    Yuan Q; Wang H; Gao P; Chen W; Lv M; Bai S; Wu J
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of metabolic dysfunction associated fatty liver disease in COVID-19.
    Chakraborty R; Sharma D; Kapoor DU; Dwivedi A; Khabiya R; Sen S
    World J Clin Cases; 2023 Feb; 11(6):1275-1286. PubMed ID: 36926128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic dysfunction-associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle-aged and older US population.
    Yang S; Cheng J; Zhang R; Sun H; Zhang H; Lyu S; Duan W
    Hepatol Res; 2022 Feb; 52(2):176-186. PubMed ID: 34751487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.
    Kemp W; Clayton-Chubb D; Majeed A; Glenister KM; Magliano DJ; Lubel J; Bourke L; Simmons D; Roberts SK
    J Gastroenterol Hepatol; 2022 Feb; 37(2):395-403. PubMed ID: 34693553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection.
    Wang MF; Wan B; Wu YL; Huang JF; Zhu YY; Li YB
    World J Gastroenterol; 2021 Jan; 27(4):336-344. PubMed ID: 33584066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic-associated fatty liver disease (MAFLD) in coeliac disease.
    Rispo A; Imperatore N; Guarino M; Tortora R; Alisi A; Cossiga V; Testa A; Ricciolino S; Fiorentino A; Morisco F
    Liver Int; 2021 Apr; 41(4):788-798. PubMed ID: 33319459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.
    Lee H; Lee YH; Kim SU; Kim HC
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2138-2147.e10. PubMed ID: 33348045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population.
    Fan J; Luo S; Ye Y; Ju J; Zhang Z; Liu L; Yang J; Xia M
    Nutr Metab (Lond); 2021 Sep; 18(1):82. PubMed ID: 34496912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Is Associated with Cervical Stromal Involvement in Endometrial Cancer Patients: A Cross-Sectional Study in South China.
    Lin X; Chen C; Jiang T; Ma J; Huang L; Huang L; Lei H; Tong Y; Huang G; Mao X; Sun P
    Curr Oncol; 2023 Mar; 30(4):3787-3799. PubMed ID: 37185400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting serum fructose is associated with metabolic dysfunction-associated fatty liver disease: A prospective study.
    Fan Y; Zhang Y; Chen C; Ying Z; Su Q; Li X; Chen Y
    Hepatol Res; 2023 Jun; 53(6):479-488. PubMed ID: 36745152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.
    Li H; Guo M; An Z; Meng J; Jiang J; Song J; Wu W
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32168920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.